Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia.
about
Human recombinant activated protein C for severe sepsisHuman recombinant activated protein C for severe sepsisHuman recombinant activated protein C for severe sepsisThe microcirculation is the motor of sepsisRecombinant human activated protein C resets thrombin generation in patients with severe sepsis - a case control study.Milrinone attenuates arteriolar vasoconstriction and capillary perfusion deficits on endotoxemic hamstersContribution of protein Z and protein Z-dependent protease inhibitor in generalized Shwartzman reaction.Alterations in the human lung proteome with lipopolysaccharide.Fluid resuscitation therapy in endotoxemic hamsters improves survival and attenuates capillary perfusion deficits and inflammatory responses by a mechanism related to nitric oxideTreatment with activated protein C (aPC) is protective during the development of myocardial fibrosis: an angiotensin II infusion model in miceMicrocirculatory assessment in daily clinical practice - not yet ready but not too far!Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shockMicrocirculatory alterations in ischemia-reperfusion injury and sepsis: effects of activated protein C and thrombin inhibition.New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated).Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management.Drotrecogin alfa (activated) in the treatment of severe sepsis.Management of sepsis in the critically ill patient: key aspects.Inflammatory response in microvascular endothelium in sepsis: role of oxidants.In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis.Effects of anticoagulant strategies on activation of inflammation and coagulation.Recombinant human activated protein C: current insights into its mechanism of actionRecombinant activated protein C treatment improves tissue perfusion and oxygenation in septic patients measured by near-infrared spectroscopy.The microcirculation in sepsis.Critical role for oxidative stress, platelets, and coagulation in capillary blood flow impairment in sepsis.Systemic versus localized coagulation activation contributing to organ failure in critically ill patients.Protein C anticoagulant system--anti-inflammatory effects.Activated protein C ameliorates impaired renal microvascular oxygenation and sodium reabsorption in endotoxemic rats.Surface modification by plasma etching impairs early vascularization and tissue incorporation of porous polyethylene (Medpor(®) ) implants.Activated protein C increases sensitivity to vasoconstriction in rabbit Escherichia coli endotoxin-induced shock.Activated protein C improves intestinal microcirculation in experimental endotoxaemia in the rat.Prognostic value of platelet-derived growth factor in patients with severe sepsis.Expansion and differentiation of human primary osteoblasts in two- and three-dimensional culture.Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11.PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injury.
P2860
Q24201123-3EE6CDC6-6E74-4F24-821E-0A5171DA91F0Q24235181-4B4BE3A2-51B9-4FB5-B97A-FC10B8053920Q24242859-7AC105A3-5A5B-4051-9660-F2D08FFBEC9BQ24633735-2562995E-901A-4C13-99BB-97CADBB0E5D1Q24813299-FE8E09C0-1251-45D1-8763-A2C092241094Q28543197-FDF7701A-4D45-4CF2-B8C5-2A312BC9CBBCQ33409905-571B3126-2CD0-46EA-AB37-9E8E041382BCQ33443562-F9BC61B9-5491-462C-96C9-581DB90344CEQ34151281-D49C0835-81E9-40FB-A8C2-D507D311AA50Q34429743-0331031F-40CF-4C5A-8B3C-3CB8D72E68FDQ34675208-98EA9D7A-6628-4E7E-AAE6-82DBF7F4EF19Q35561370-2F3665B4-21F9-40D6-BF95-5564E2A0A18FQ36259598-57D36221-286E-46A2-892E-A4BCB8AFC3DDQ36259602-0EE926C6-70C7-431D-BCAD-718647CF1907Q36261456-B55D52BB-F816-44A5-93CD-1D12A5F2F0D0Q36607385-7D3AA198-5DDE-4739-9C8C-07CDD614B354Q36613922-C0D4FC7F-71A9-4F24-B0D1-4BD446A8F388Q36661663-CEC34F3F-1003-4E3B-92EA-B82047D58A02Q36755136-FECD38DB-A480-4810-B0EB-B10613BF3611Q36842724-4988F146-D66B-40C8-A0C5-1222051701B8Q37082968-45F51657-5159-4C58-8EA9-928EDAC86502Q37449940-DF340792-6976-4AED-8ADA-34E4A9F449E6Q37773794-039858D5-0ABE-4CDA-8B0D-0C2A25B85902Q37825577-BA48CD0B-9B0C-4891-BFC5-88045D76353EQ37909137-5A217B86-B5D3-49DF-B152-8DCC2269FC8DQ37913122-D8D63D52-D6A3-4094-9DF8-B960BA65ED32Q39110945-228EFC5E-C7F4-4EA6-A302-E5A66D5FFA64Q40503651-6232312D-5DE0-4754-8860-CEAC4B4708C0Q42904795-50235F3D-B1A0-40E9-A079-0A9CD873B218Q42962104-A5B7A077-35F2-4E30-A5AF-D814A3F70A9AQ43782027-2A7714D1-2514-4502-961E-6A2E8B5CD0A5Q46118918-20699A4C-B1C2-4BCE-A883-A5896B7E586CQ46956939-C57B4E50-B54D-4AF2-A5EE-59DA1D68E869Q48533407-0A4F0B1A-7B84-4E30-A881-7F60B0D9A2BD
P2860
Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Microhemodynamic and cellular ...... n C action during endotoxemia.
@en
Microhemodynamic and cellular ...... n C action during endotoxemia.
@nl
type
label
Microhemodynamic and cellular ...... n C action during endotoxemia.
@en
Microhemodynamic and cellular ...... n C action during endotoxemia.
@nl
prefLabel
Microhemodynamic and cellular ...... n C action during endotoxemia.
@en
Microhemodynamic and cellular ...... n C action during endotoxemia.
@nl
P2093
P1476
Microhemodynamic and cellular ...... n C action during endotoxemia.
@en
P2093
Brigitte Vollmar
Dietrich Inthorn
Friedrich W Schildberg
Jan Fertmann
Johannes N Hoffmann
Matthias W Laschke
Michael D Menger
P304
P356
10.1097/01.CCM.0000120058.88975.42
P407
P577
2004-04-01T00:00:00Z